doc. MUDr. Alexandr Poprach, Ph.D.
Associate professor, Comprehensive Cancer Care Department
Total number of publications: 144
2018
-
Impact of Delayed Addition of Anti-EGFR Monoclonal Antibodies on the Outcome of First-Line Therapy in Metastatic Colorectal Cancer Patients: a Retrospective Registry-Based Analysis
Targeted Oncology, year: 2018, volume: 13, edition: 6, DOI
-
Incidence of Hippocampal Metastases: Laterality and Implications for Unilateral Hippocampal Avoiding Whole Brain Radiotherapy
BioMed Research International, year: 2018, volume: 2018, edition: 2459608, DOI
-
Pazopanib for Metastatic Renal Cell Carcinoma: A Registry-based Analysis of 426 Patients
Anticancer Research, year: 2018, volume: 38, edition: 1, DOI
-
The Association of Baseline Serum Tumour Markers with Outcome of Patients with Metastatic Colorectal Cancer Treated with Anti-EGFR Monoclonal Antibodies in the First Line
JOURNAL OF CANCER, year: 2018, volume: 9, edition: 22, DOI
2017
-
Detection of let-7 miRNAs in urine supernatant as potential diagnostic approach in non-metastatic clear-cell renal cell carcinoma
Biochemia Medica, year: 2017, volume: 27, edition: 2, DOI
-
Hepatopatie při léčbě pazopanibem
Farmakoterapie, year: 2017, volume: 13, edition: 2
-
Kontroverze v pooperační léčbě low-grade gliomů
Klinická onkologie, year: 2017, volume: 30, edition: 5, DOI
-
MicroRNAs as outcome predictors in patients with metastatic colorectal cancer treated with bevacizumab in combination with FOLFOX
Oncology letters, year: 2017, volume: 14, edition: 1, DOI
-
Outcomes of Patients With Long-Term Treatment Response to Vascular Endothelial Growth Factor-Targeted Therapy for Metastatic Renal Cell Cancer
CLINICAL GENITOURINARY CANCER, year: 2017, volume: 15, edition: 6, DOI
-
Prognostic role of serum C-reactive protein in patients with advanced-stage NSCLC treated with pemetrexed
Neoplasma, year: 2017, volume: 64, edition: 4, DOI